19 top tech platforms for value-based care, population health

Black Book Research ranked the top vendors for population health and value-based care for a Feb. 25 report.

Advertisement

The researcher surveyed 2,230 healthcare professionals on 18 key performance indicators, including effectiveness of data integration, seamlessness of interoperability, and timeliness of data availability.

Here are the No. 1 platforms by category, according to the report:

1. AI-driven population health solutions: Innovaccer

2. Core EHR system population health platforms: Epic Healthy Planet

3. Population health reporting and analytics (providers): SPH Analytics (Press Ganey)

4. Population health reporting, analytics and benchmarking (payers and employers): Inovalon

5. Customer relationship management: Salesforce Health Cloud

6. Digital rounding: CipherHealth (CipherRounds)

7. EHR-centric virtual care platforms: Oracle Health (Virtual Health)

8. Healthcare experience management: Press Ganey

9. Interactive patient systems: pCare by Uniguest

10. Outsourced virtual clinician services: Equum Medical

11. Patient communications: RevSpring (Talksoft)

12. Patient education: Elsevier Patient Education (ExitCare)

13. Patient portals: Epic MyChart

14. Patient-driven care management: GetWell Loop

15. Remote patient monitoring: Biofourmis

16. Social determinants of health networks: Signify Health

17. Video conferencing platforms: Doximity Dialer

18. Virtual care platforms (non-EHR): Andor Health (ThinkAndor)

19. Virtual sitting and nursing: Care.ai

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.